Print

SuppreMol Appoints Dr. Robert Phelps as Head of Business Development & Licensing  
2/8/2010 12:07:39 PM

Martinsried/Munich, Germany, February 8, 2010 -- SuppreMol GmbH, a privately held biopharmaceutical company developing novel therapeutics for the treatment of autoimmune diseases, today announced that Dr. Robert Phelps has joined the Company as Head of Business Development & Licensing.
//-->